China Money Network
Login
Join

Sequoia China Leads $150 Million Round In Drug Developer Visen Pharma

  • January 13, 2021 — 08:47 CST

This Data Is Locked!

This area is available only to Subscribers.

Chinese new endocrine drug developer Visen Pharma announced the completion of US$150 million in Series B financing, led by Sequoia China Fund. Aobo Capital, Sherpa... [DATA LOCKED]

UNLOCK DATA

Follow the Money & Subscribe for Access to the Best Data and Intelligence on Chinese Venture Capital Deals

Join

Access Thousands of Data Points to Monitor Chinese Private Equity Deal Movement and Relationships

Already Have an Account?

Login
Related Topics:

Related Data: